BridgeMD
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with long-acting Somatostatin Analogues – ATSA trial
EU CTIS ID: 2023-505884-35-00
What this study is testing
The effect of continued LA-SSA use on the absorbed dose in tumor lesions during PRRT.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age ≥ 18 years
- Able to provide spoken and written informed consent for the trial
- Histopathological confirmed neuroendocrine tumor
- Fulfill the clinical criteria for PRRT
- At least one soft tissue lesion > 2 cm
- Aimed administered activity of 7400 MBq
You likely can't join if
- Not possible to discontinue LA-SSA for 4-6 weeks
- Use of short-acting somatostatin analogues
- Inability to comply to the study procedures
- Factors that might affect the biodistribution (for example, indication for furosemide directly after PRRT infusion, limited fluid intake, any renal catheters, etc.)
- Pregnancy and lactating female patients
See the full eligibility criteria
- Age ≥ 18 years
- Able to provide spoken and written informed consent for the trial
- Histopathological confirmed neuroendocrine tumor
- Fulfill the clinical criteria for PRRT
- At least one soft tissue lesion > 2 cm
- Aimed administered activity of 7400 MBq
- ECOG score (performance status) 0-2
- Not possible to discontinue LA-SSA for 4-6 weeks
- Use of short-acting somatostatin analogues
- Inability to comply to the study procedures
- Factors that might affect the biodistribution (for example, indication for furosemide directly after PRRT infusion, limited fluid intake, any renal catheters, etc.)
- Pregnancy and lactating female patients
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.